Cargando…

Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas

Pheochromocytoma, neuroendocrine tumor, single cell RNA-sequencing, transcriptome, heterogeneity, SDHB, RET, paraganglinoma; Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors with varied genetic makeup and are associated with high cardiovascular morbidity and a variable r...

Descripción completa

Detalles Bibliográficos
Autores principales: Brazda, Peter, Ruiz-Moreno, Cristian, Megchelenbrink, Wout L., Timmers, Henri J. L. M., Stunnenberg, Hendrik G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421253/
https://www.ncbi.nlm.nih.gov/pubmed/36046044
http://dx.doi.org/10.3389/fonc.2022.965168
_version_ 1784777555477266432
author Brazda, Peter
Ruiz-Moreno, Cristian
Megchelenbrink, Wout L.
Timmers, Henri J. L. M.
Stunnenberg, Hendrik G.
author_facet Brazda, Peter
Ruiz-Moreno, Cristian
Megchelenbrink, Wout L.
Timmers, Henri J. L. M.
Stunnenberg, Hendrik G.
author_sort Brazda, Peter
collection PubMed
description Pheochromocytoma, neuroendocrine tumor, single cell RNA-sequencing, transcriptome, heterogeneity, SDHB, RET, paraganglinoma; Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors with varied genetic makeup and are associated with high cardiovascular morbidity and a variable risk of malignancy. The source of the transcriptional heterogeneity of the disease and the underlying biological processes that determine the outcome of PCPG remain largely unclear. We focused on PCPG tumors with germline SDHB and RET mutations, which represent distinct prognostic groups with worse or better prognoses, respectively. We applied single-nuclei RNA sequencing (snRNA-seq) to tissue samples from 11 patients and found high patient-to-patient transcriptome heterogeneity in neuroendocrine tumor cells. The tumor microenvironment also showed heterogeneous profiles, mainly contributed by macrophages of the immune cell clusters and Schwann cells of the stroma. By performing non-negative matrix factorization, we identified common transcriptional programs active in RET and SDHB, as well as distinct modules, including neuronal development, hormone synthesis and secretion, and DNA replication. Similarities between the transcriptomes of the tumor cells and those of the chromaffin- and precursor cell types suggests different developmental stages at which PC and PG tumors appear to be arrested.
format Online
Article
Text
id pubmed-9421253
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94212532022-08-30 Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas Brazda, Peter Ruiz-Moreno, Cristian Megchelenbrink, Wout L. Timmers, Henri J. L. M. Stunnenberg, Hendrik G. Front Oncol Oncology Pheochromocytoma, neuroendocrine tumor, single cell RNA-sequencing, transcriptome, heterogeneity, SDHB, RET, paraganglinoma; Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors with varied genetic makeup and are associated with high cardiovascular morbidity and a variable risk of malignancy. The source of the transcriptional heterogeneity of the disease and the underlying biological processes that determine the outcome of PCPG remain largely unclear. We focused on PCPG tumors with germline SDHB and RET mutations, which represent distinct prognostic groups with worse or better prognoses, respectively. We applied single-nuclei RNA sequencing (snRNA-seq) to tissue samples from 11 patients and found high patient-to-patient transcriptome heterogeneity in neuroendocrine tumor cells. The tumor microenvironment also showed heterogeneous profiles, mainly contributed by macrophages of the immune cell clusters and Schwann cells of the stroma. By performing non-negative matrix factorization, we identified common transcriptional programs active in RET and SDHB, as well as distinct modules, including neuronal development, hormone synthesis and secretion, and DNA replication. Similarities between the transcriptomes of the tumor cells and those of the chromaffin- and precursor cell types suggests different developmental stages at which PC and PG tumors appear to be arrested. Frontiers Media S.A. 2022-08-15 /pmc/articles/PMC9421253/ /pubmed/36046044 http://dx.doi.org/10.3389/fonc.2022.965168 Text en Copyright © 2022 Brazda, Ruiz-Moreno, Megchelenbrink, Timmers and Stunnenberg https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Brazda, Peter
Ruiz-Moreno, Cristian
Megchelenbrink, Wout L.
Timmers, Henri J. L. M.
Stunnenberg, Hendrik G.
Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
title Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
title_full Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
title_fullStr Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
title_full_unstemmed Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
title_short Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
title_sort extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421253/
https://www.ncbi.nlm.nih.gov/pubmed/36046044
http://dx.doi.org/10.3389/fonc.2022.965168
work_keys_str_mv AT brazdapeter extensivepatienttopatientsinglenucleustranscriptomeheterogeneityinpheochromocytomasandparagangliomas
AT ruizmorenocristian extensivepatienttopatientsinglenucleustranscriptomeheterogeneityinpheochromocytomasandparagangliomas
AT megchelenbrinkwoutl extensivepatienttopatientsinglenucleustranscriptomeheterogeneityinpheochromocytomasandparagangliomas
AT timmershenrijlm extensivepatienttopatientsinglenucleustranscriptomeheterogeneityinpheochromocytomasandparagangliomas
AT stunnenberghendrikg extensivepatienttopatientsinglenucleustranscriptomeheterogeneityinpheochromocytomasandparagangliomas